Back
PubMedNew recommendationProphylactic surgery

Are current Polish guidelines for prophylactic mastectomy sufficient?

Stachowski A, Cybulski C, Gronwald J et al.Hered Cancer Clin Pract 2026 · June 2026
Relevance score
7/10
Disease / domain
Prophylactic mastectomy — update of Polish recommendations for hereditary breast cancer predispositions
Source
PubMed
PMID 42243898
Share on LinkedIn

Gene / mechanism

Revision of Polish ministerial criteria for prophylactic mastectomy in light of new data on intermediate-penetrance genes (PALB2, CHEK2, ATM)

Summary

Tasked with updating Polish ministerial recommendations on prophylactic mastectomy qualification, the International Hereditary Cancer Center of Szczecin publishes a revision incorporating new penetrance data for BRCA1/2, PALB2, CHEK2, and ATM. Current criteria are deemed insufficient: they notably exclude PALB2 carriers who have breast cancer risk comparable to BRCA2, and underrepresent intermediate-penetrance genes in surgical indications. The publication proposes an updated framework including these genes.

Synthesis written by Geno'X. For the full original abstract, please refer to the source publication.

Analysis

The update of Polish recommendations for prophylactic mastectomy exemplifies the necessary evolution in all countries that have not yet integrated intermediate-penetrance genes (PALB2, CHEK2, ATM) into their surgical indications. This revision is relevant for all oncogenetics specialists working with national recommendations still centered on BRCA1/2.

Why this score?

Clinical impact: 3/3 · Evidence strength: 2/3 · Novelty: 1/2 · Sample size: 1/1 · Publication status: 0/1 → Total: 7/10

Keywords

prophylactic mastectomyPALB2CHEK2ATMguidelines
Weekly report in your inbox

Every Wednesday · Annotated selection · Free · Unsubscribe anytime